All News Archive

February 18, 2026

Vanderbilt Health remembers C. Leon Partain, former chair of Radiology

A Tennessee native, C. Leon Partain is celebrated for being instrumental in bringing the first MRI and PET/CT machines to the Medical Center.

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
February 18, 2026

Vanderbilt research offers new hope for preventing repeated C. diff infections

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.

February 18, 2026

Novel vaccine protects against C. diff disease and recurrence

New study represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.

February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

February 13, 2026

30 years of changing health care culture: How Vanderbilt Health’s CPPA pioneered professional accountability 

Three decades later, CPPA is a cornerstone of health care culture transformation, around the U.S. and the world reaching hundreds of thousands of clinicians.

(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.